Vaping in Public Spaces

We believe vaping shouldn’t be stigmatized, and that vapers should be able to use their products freely in public spaces.  Vape products do not contain tobacco, do not emit smoke, do not generate side-stream emissions, and pose no known risk to bystanders based on current science. Smoke-free tobacco legislation, such as public place smoking bans, should not be applied or extended to vape products; vaping should be treated differently and regulated separately to combustible tobacco. 

We believe vapers should be able to integrate their products into their daily lives, in order to maintain their cigarette abstinence, and that blanket vaping bans are severely counter-productive to tobacco harm reduction. Adult consumers should vape responsibly, indoors, and outdoors, with consideration and respect for others around them. 

No Second-Hand Smoke

Our published scientific research shows that indoor vaping does not release chemicals or toxins into the air at levels that would pose any air quality issue to bystanders. Ambient air in a room in which blu products were used fully complied with indoor air quality regulations.

The research has also shown the difference between vapour and smoke. Exhaled vapour particles are liquid droplets that evaporate within ten seconds of exhalation. In contrast, combustible tobacco particles (emitted from the burning end of a cigarette and the smoke exhaled) will linger in a room for much longer.

Regulators considering legislation on indoor vaping should weigh up the existing scientific evidence for vapour products. Regulators should also be cognisant that forcing vapers – the majority of whom are smokers trying to reduce or quit smoking – to share a space with smokers could have the unintended consequence of undermining their efforts to quit.

Scientific Research

A 2015 Public Health England report concluded that exposure to nicotine and other chemicals that may be present in exhaled vapour aerosol is negligible, with chemical analyses to date indicating that exhaled vapour aerosols are unlikely to warrant concern to bystanders. In the subsequent 2018 E-Cigarette Evidence Review, Public Health England re-affirmed this conclusion by stating:

To date, there have been no identified health risks of passive vaping to bystanders.”

The UK Government Science & Technology Committee E-Cigarette Report, UK National Health Service, Chartered Institute for Environmental Health, Cancer Research UK and many others all share this view. The British Medical Association stated in its key messages for policymakers:

Although research in this area remains limited, there is a lack of evidence that exposure to the constituents of e-cigarette vapour poses specific health risks to bystanders”.

blu was founded in the USA in 2009 and is one of the original e-cigarette brands. It was acquired by Fontem Ventures in 2015. As one of the world’s most recognizable vape brands, blu offers adult smokers’ choice through high-quality e-vapour products and e-liquids.

Nerudia was established in 2013 and became part of Imperial Brands in 2017. It is the home of innovation and technology R&D for Next Generation Products (NGP) which includes e-vapour, heated tobacco and oral nicotine delivery. Nerudia is dedicated to creating a world where smokers have choice.

Fontem Ventures is a subsidiary of Imperial Brands PLC, a global consumer organisation and the fourth largest international tobacco company in the world, operating across 120 markets.

[contact-form-7 404 "Not Found"]